EVAX Articles, Evaxion Biotech A/S - From 01/24/24

Shares of BlackBerry Limited (NYSE: BB) fell sharply during Wednesday’s session after the company announced a proposed private offering of $1...

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 150 points on Wednesday. The Dow traded up 0.36% to 38,0...

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 100 points on Wednesday. Following the market opening Wednesday,...

Shares of Netflix, Inc. (NASDAQ: NFLX) shares rose sharply in today’s pre-market trading as the company reported better-than-expected sales ...

Shares of 3M Company (NYSE: MMM) fell sharply during Tuesday’s session after the company reported better-than-expected fourth-quarter EPS, bu...

Proof of Concept – Evaxion's AI-Immunology™ platform demonstrates success in designing precision cancer vaccines in hematological c...

EVX-01 is Evaxion's lead clinical asset based upon its AI-Immunology™ platform and has recently published a phase 2 clinical update c...

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian...

Initial EVX-01 Phase 2 data confirms the strong Phase 1 results After undergoing EVX-01 treatment, a significant and continuous tumor reduction...

Data from Evaxion's two personalized cancer vaccine clinical trials to be presented at the annual meeting of the Society for Immunotherapy o...